AQN vs BKH

The deterministic health scores indicate significant concerns, with a Piotroski F-Score of 4/9 signaling borderline financial stability and no available Altman Z-Score limiting distress risk assessment. Despite a recent 1Y price surge of +47.5%, the stock trades at a steep valuation (P/E 91.14 vs sector avg 19.73) while reporting a negative profit margin (-1.11%) and an unsustainable dividend payout ratio (371.43%). However, strong operating metrics like 25.07% operating margin, improving EPS trends (+12.5% YoY), and a 4.06% dividend yield provide some support. The lack of insider activity and mixed analyst sentiment (hold) further justify a cautious stance.

The Advanced Deterministic Scorecard shows a Piotroski F-Score of 6/9, indicating stable financial health, but the absence of an Altman Z-Score limits distress risk assessment. The stock trades above the Graham defensive fair value of $66.70 at $71.68, supported by a forward P/E below sector average and solid dividend yield of 3.74%. Profitability metrics are healthy with strong gross and operating margins, though ROE and ROA are modest. Earnings growth has rebounded recently, but insider selling and weak technical trend signal caution despite analyst buy recommendation.